Home
Conditions
Amyloidosis

Clinical trial condition

Amyloidosis

Explore clinical trials studying Amyloidosis. Study availability and eligibility vary by location and protocol.

187 public trials 49 recruiting studies

Refine in advanced search Browse all conditions

Amyloidosis trial results

Enrolling by Invitation

An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

NCT05667493

Conditions: Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +2 more
Locations: Mayo Clinic Scottsdale, Arizona, United States

Cedars-Sinai Medical Center Beverly Hills, California, United States

Altman Clinical and Translational Research Institute - Center for Clinical Research La Jolla, California, United States

University Of California San Francisco Urology Practice San Francisco, California, United States

View all 134 locations

View Trial Details

Enrolling by Invitation

A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

NCT06679946

Conditions: Amyloidosis, Amyloidosis, Hereditary, Transthyretin-Related, Cardiomyopathies, +6 more
Locations: Clinical Trial Site Phoenix, Arizona, United States

Clinical Trial Site Beverly Hills, California, United States

Clinical Trial Site La Jolla, California, United States

Clinical Trial Site Stanford, California, United States

View all 87 locations

View Trial Details

Enrolling by Invitation

Sahlgrenska Cardiomyopathy Project

NCT03527342

Conditions: Amyloidosis, Amyloidosis; Heart (Manifestation), Aortic Stenosis, Subvalvular, +27 more
Locations: Göteborg University, Sahlgrenska Universitetssjukhuset Gothenburg, Sweden

View Trial Details

Not Yet Recruiting

Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System

NCT07721350

Conditions: Amyloidosis, Behavior, Blood Protein Disorders, +21 more
Locations: Hôpital Lyon-Sud Pierre-Bénite, France

View Trial Details

Not Yet Recruiting

A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of NXC-201 Compared With Daratumumab With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) in Newly Diagnosed Systemic AL Amyloidosis

NCT07709715

Conditions: Amyloidosis, Light Chain (AL) Amyloidosis, Metabolic Diseases, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis

NCT07695701

Conditions: Alzheimer Disease, Amyloid Cardiomyopathy, Amyloid Neuropathies, +26 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

PET/CT Imaging in Carriers of TTR Mutations

NCT07591038

Conditions: ATTR, ATTR Gene Mutation, Amyloidosis, +8 more
Locations: UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Not Yet Recruiting

Early Detection of Concealed Cardiac Amyloidosis Using AI-ECG and CT-Derived Extracellular Volume in Patients With Atrial Fibrillation

NCT07567508

Conditions: Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +20 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Not Yet Recruiting

PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels

NCT07538518

Conditions: Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidogenic Transthyretin (ATTR) Amyloidosis, +14 more
Locations: One Boston Medical Center Place Boston, Massachusetts, United States

Columbia University Irving Medical Center New York, United States

Bill and Rita Clements Advanced Medical Imaging Center Dallas, Texas, United States

View Trial Details

Not Yet Recruiting

Impact of a Cardiac Rehabilitation Program on Patients With Cardiac Amyloidosis

NCT07494942

Conditions: Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +15 more
Locations: KRIEF Montpellier, France

View Trial Details

Amyloidosis

Amyloidosis trial results

Related conditions